...
机译:I期I试验放射治疗和索拉非尼在不可切除的肝转放酶中
Univ Toronto Princess Margaret Canc Ctr Dept Radiat Oncol 610 Univ Ave Toronto ON M5G 0A6;
Univ Toronto Princess Margaret Canc Ctr Dept Radiat Oncol 610 Univ Ave Toronto ON M5G 0A6;
Univ Toronto Princess Margaret Canc Ctr Dept Biostat Toronto ON Canada;
Univ Toronto Princess Margaret Canc Ctr Dept Radiat Phys Toronto ON Canada;
Univ Toronto Princess Margaret Canc Ctr Dept Radiat Oncol 610 Univ Ave Toronto ON M5G 0A6;
Univ Toronto Princess Margaret Canc Ctr Dept Radiat Oncol 610 Univ Ave Toronto ON M5G 0A6;
Univ Toronto Princess Margaret Canc Ctr Dept Radiat Oncol 610 Univ Ave Toronto ON M5G 0A6;
Univ Toronto Princess Margaret Canc Ctr Dept Radiat Oncol 610 Univ Ave Toronto ON M5G 0A6;
Univ Toronto Princess Margaret Canc Ctr Dept Radiat Oncol 610 Univ Ave Toronto ON M5G 0A6;
Univ Toronto Princess Margaret Canc Ctr Dept Radiat Oncol 610 Univ Ave Toronto ON M5G 0A6;
Univ Toronto Princess Margaret Canc Ctr Dept Radiat Oncol 610 Univ Ave Toronto ON M5G 0A6;
Univ Toronto Princess Margaret Canc Ctr Dept Med Oncol &
Hematol Toronto ON Canada;
Univ Toronto Princess Margaret Canc Ctr Dept Radiat Oncol 610 Univ Ave Toronto ON M5G 0A6;
Sorafenib; Radiotherapy; Liver metastases;
机译:I期I试验放射治疗和索拉非尼在不可切除的肝转放酶中
机译:立体定向放射疗法是否可治疗无法切除的肝转移? 2期试验的初步报告
机译:一线放化疗联合调强放疗再化疗的同步性不可切除远距离转移性直肠腺癌的二期试验
机译:Sorafenib之外的肝细胞癌中的分子疗法:III期试验失败的课程和新型靶标
机译:开发和评估用于肝转移放疗的超声引导跟踪和门控系统。
机译:一线放化疗联合调强放射治疗然后化疗治疗同步性不可切除的远处转移性直肠腺癌的二期试验
机译:常规化疗和索拉非尼的综合阶段II / III综合控制试验的议定书或没有立体定向体辐射治疗的非常规不可切除的肝细胞癌患者